Synthesis and biological evaluation of phenyl-1H-1,2,3-triazole derivatives as anti-inflammatory agents. 2015

Tae Woo Kim, and Yeonjoong Yong, and Soon Young Shin, and Hyeryoung Jung, and Kwan Ha Park, and Young Han Lee, and Yoongho Lim, and Kang-Yeoun Jung
Department of Biochemical Engineering, Gangneung-Wonju National University, Gangwon 210-702, Republic of Korea.

Rapid and efficient synthesis of a phenyl-1H-1,2,3-triazole library enabled cost-effective biological testing of a range of novel non-steroidal anti-inflammatory drugs with potential for improved drug efficacy and toxicity profiles. Anti-inflammatory activities of the phenyl-1H-1,2,3-triazole analogs synthesized in this report were assessed using the xylene-induced ear edema model in mice. At least four analogs, 2a, 2b, 2c, and 4a, showed more potent effects than the reference anti-inflammatory drug diclofenac at the same dose of 25 mg/kg. To explore relationships between the structural properties of phenyl-1H-1,2,3-triazole analogs and their anti-inflammatory activities in xylene-induced ear edema, comparative molecular field analysis was performed, and pharmacophores showing good anti-inflammatory activities were identified based on an analysis of contour maps obtained from comparative molecular field analysis. The anti-inflammatory effect on the molecular level was tested by the expression of tumor necrosis factor-alpha induced COX-2 using Western blots. Because the addition of the analog 2c caused the expression change of TNF-α induced COX-2, the molecular binding mode between 2c and COX-2 was elucidated using in silico docking.

UI MeSH Term Description Entries
D008297 Male Males
D004423 Ear The hearing and equilibrium system of the body. It consists of three parts: the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR. Sound waves are transmitted through this organ where vibration is transduced to nerve signals that pass through the ACOUSTIC NERVE to the CENTRAL NERVOUS SYSTEM. The inner ear also contains the vestibular organ that maintains equilibrium by transducing signals to the VESTIBULAR NERVE. Vestibulocochlear System,Vestibulocochlear Apparatus,Apparatus, Vestibulocochlear,Ears,System, Vestibulocochlear
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D014992 Xylenes A family of isomeric, colorless aromatic hydrocarbon liquids, that contain the general formula C6H4(CH3)2. They are produced by the destructive distillation of coal or by the catalytic reforming of petroleum naphthenic fractions. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Dimethylbenzenes,Xylene
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Tae Woo Kim, and Yeonjoong Yong, and Soon Young Shin, and Hyeryoung Jung, and Kwan Ha Park, and Young Han Lee, and Yoongho Lim, and Kang-Yeoun Jung
August 2017, Bioorganic & medicinal chemistry letters,
Tae Woo Kim, and Yeonjoong Yong, and Soon Young Shin, and Hyeryoung Jung, and Kwan Ha Park, and Young Han Lee, and Yoongho Lim, and Kang-Yeoun Jung
January 2019, Bioorganic & medicinal chemistry letters,
Tae Woo Kim, and Yeonjoong Yong, and Soon Young Shin, and Hyeryoung Jung, and Kwan Ha Park, and Young Han Lee, and Yoongho Lim, and Kang-Yeoun Jung
May 2018, RSC advances,
Tae Woo Kim, and Yeonjoong Yong, and Soon Young Shin, and Hyeryoung Jung, and Kwan Ha Park, and Young Han Lee, and Yoongho Lim, and Kang-Yeoun Jung
August 2017, Bioorganic & medicinal chemistry letters,
Tae Woo Kim, and Yeonjoong Yong, and Soon Young Shin, and Hyeryoung Jung, and Kwan Ha Park, and Young Han Lee, and Yoongho Lim, and Kang-Yeoun Jung
March 2012, Journal of medicinal chemistry,
Tae Woo Kim, and Yeonjoong Yong, and Soon Young Shin, and Hyeryoung Jung, and Kwan Ha Park, and Young Han Lee, and Yoongho Lim, and Kang-Yeoun Jung
January 2012, TheScientificWorldJournal,
Tae Woo Kim, and Yeonjoong Yong, and Soon Young Shin, and Hyeryoung Jung, and Kwan Ha Park, and Young Han Lee, and Yoongho Lim, and Kang-Yeoun Jung
January 2020, Current topics in medicinal chemistry,
Tae Woo Kim, and Yeonjoong Yong, and Soon Young Shin, and Hyeryoung Jung, and Kwan Ha Park, and Young Han Lee, and Yoongho Lim, and Kang-Yeoun Jung
January 2022, Anti-cancer agents in medicinal chemistry,
Tae Woo Kim, and Yeonjoong Yong, and Soon Young Shin, and Hyeryoung Jung, and Kwan Ha Park, and Young Han Lee, and Yoongho Lim, and Kang-Yeoun Jung
September 2018, European journal of medicinal chemistry,
Tae Woo Kim, and Yeonjoong Yong, and Soon Young Shin, and Hyeryoung Jung, and Kwan Ha Park, and Young Han Lee, and Yoongho Lim, and Kang-Yeoun Jung
December 2014, Organic and medicinal chemistry letters,
Copied contents to your clipboard!